You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective
|
|---|---|
| Published in |
World Journal of Surgical Oncology, July 2008
|
| DOI | 10.1186/1477-7819-6-77 |
| Pubmed ID | |
| Authors |
Ravindra S Date, Nicholas A Stylianides, Kishore G Pursnani, Jeremy B Ward, Muntzer M Mughal |
| Abstract |
Surgical resection has remained the mainstay of treatment of GIST with a 5-year-survival of 28-35%. Tyrosine kinase inhibitor (Imatinib) has revolutionised the treatment of these tumours. The current research is directed towards expanding the role of this drug in the treatment of GIST. We present our experience of managing GIST in this institute. |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 6% |
| Luxembourg | 1 | 6% |
| Unknown | 14 | 88% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Postgraduate | 3 | 19% |
| Professor > Associate Professor | 3 | 19% |
| Student > Ph. D. Student | 2 | 13% |
| Other | 2 | 13% |
| Student > Doctoral Student | 2 | 13% |
| Other | 2 | 13% |
| Unknown | 2 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 69% |
| Agricultural and Biological Sciences | 1 | 6% |
| Environmental Science | 1 | 6% |
| Unknown | 3 | 19% |